RCUS
Arcus Biosciences, Inc (RCUS) Arcus Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides a Pipeline Update
Arcus Biosciences, Inc (NYSE: RCUS) Q4 2025 Earnings Release
Arcus Biosciences, Inc (RCUS) Arcus Presents New Data for its HIF-2a Inhibitor Casdatifan, Which Showed Progression-Free Survival Beyond One Year in Late-Line Kidney Cancer
Arcus Biosciences, Inc (NYSE: RCUS) FY 2026 Other Release
Arcus Biosciences, Inc (RCUS) Q4 2025 Earnings Call
Arcus Biosciences, Inc (NYSE: RCUS) Q4 2025 Earnings Conference
Arcus Biosciences, inc (RCUS) Arcus Biosciences to Report Second Quarter 2021 Financial Results & Recent Corporate Highlights
Arcus Biosciences, inc (NYSE: RCUS) Q2 2021 Earnings Conference